v3.25.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 57,006 $ 46,339
Short-term investments 121,979 150,917
Accounts receivable, net 27,142 11,804
Inventory 28,491 27,886
Prepaid expenses and other current assets 44,409 31,360
Total current assets 279,027 268,306
Restricted cash 741  
Long-term investments 22,240 5,482
Property and equipment, net 82,965 85,365
Goodwill 1,931 1,931
Other intangible assets 5,169 5,265
Other assets 19,624 26,757
Total assets 411,697 393,843
Current liabilities:    
Accounts payable 10,257 6,792
Accrued expenses and other current liabilities 30,915 40,293
Senior convertible notes - current 36,166  
Liability for sale of future royalties - current 13,344 12,283
Financing liability - current 10,190 10,062
Deferred revenue — current 10,954 12,407
Total current liabilities 111,826 81,837
Liability for sale of future royalties - long term 137,230 137,362
Financing liability - long term 93,476 93,877
Deferred revenue — long term 45,472 51,160
Recognized loss on purchase commitments — long term 66,076 58,204
Operating lease liability 10,656 11,645
Milestone liabilities 2,003 2,523
Senior convertible notes   36,051
Total liabilities 466,739 472,659
Commitments and contingencies (Note 14)
Stockholders' deficit:    
Undesignated preferred stock, $0.01 par value - 10,000,000 shares authorized; no shares issued or outstanding as of June 30, 2025 or December 31, 2024
Common stock, $0.01 par value - 800,000,000 shares authorized; 306,332,133 and 302,959,782 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively 3,063 3,029
Additional paid-in capital 3,128,631 3,118,865
Accumulated other comprehensive income 1,257 1,109
Accumulated deficit (3,187,993) (3,201,819)
Total stockholders' deficit (55,042) (78,816)
Total liabilities and stockholders' deficit $ 411,697 $ 393,843